skip to main content
Harris Beach Murtha Attorneys at Law
Capabilities
People
main menu
Harris Beach Murtha Attorneys at Law
  • Capabilities
  • People
  • Capabilities
  • People
About
About
Inclusion and Engagement
Social Impact
Lateral Opportunities
About
Inclusion and Engagement
Social Impact
Lateral Opportunities
Resources
Insights
News
Events
Insights
News
Events
Careers
Contact
Offices
In The News
July 22, 2026

amNY Law Publishes Attorney’s Opinion on SCOTUS Roundup Decision

Authors and Contacts

Kelly Jones Howell

Facebook
(Twitter)
LinkedIn
Email
Copy Page Link

Harris Beach Murtha Partner Kelly Jones Howell’s opinion article on a U.S. Supreme Court decision strengthening preemption defenses for FDA-regulated products recently appeared in amNY Law.

Kelly, leader of the firm’s Medical and Life Sciences Practice Group, discussed the 7-2 ruling in Monsanto Co. v. Durnell that came after decades of glyphosate litigation. Glyphosate is the active herbicide in Monsanto’s Roundup weedkiller.

Despite the World Health Organization’s International Agency for Research on Cancer classifying glyphosate as “probably carcinogenic” – a move that led to thousands of lawsuits producing billions in damages against Monsanto and Roundup – the U.S. Environmental Protection Agency (EPA) has conducted its own research and repeatedly ruled Roundup and similar herbicides do not need to carry a cancer warning. Despite the EPA determination, some courts have attempted to force the cancer-warning labels on to the herbicides.

The Supreme Court ruled such lawsuits are barred because the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) authorizes the EPA to regulate the use, sale and labeling of pesticides and it includes a requirement prohibiting states from imposing additional labeling requirements.

“While this is a major victory for Monsanto, it should also be viewed as a win for medical device and over-the-counter drug manufacturers that market products regulated by federal agencies, as the Supreme Court ruling holds that preemption clauses found in statutes governing federal agencies bar states from adding additional regulatory requirements,” Kelly wrote.

Harris Beach Murtha writes monthly opinion pieces for the publication. You can read Kelly’s full article here.

Authors and Contacts

Partner Kelly Jones Howell

Kelly Jones Howell

Member

Related Legal Practices

Medical and Life Sciences

Related Focuses

Pharmacy Law
Facebook
(Twitter)
LinkedIn
Email
Copy Page Link

Contact Us

Harris Beach Murtha Attorneys at Law
  • Contact
  • Offices
  • Privacy Policy
  • Legal Disclaimer
  • Site Map
  • Contact
  • Offices
  • Privacy Policy
  • Legal Disclaimer
  • Site Map
Payment Portal
X-twitter Facebook Linkedin Instagram
Attorney Advertising. Prior results do not guarantee a similar outcome. © 2026 Harris Beach Murtha Cullina PLLC
TRUSTe
Harris Beach Murtha Attorneys at Law
Back to Top

News

amNY Law Publishes Attorney’s Opinion on SCOTUS Roundup Decision

Capabilities
People
Harris Beach Murtha Attorneys at Law
In The News
July 22, 2026

amNY Law Publishes Attorney’s Opinion on SCOTUS Roundup Decision

News

Harris Beach Murtha Partner Kelly Jones Howell’s opinion article on a U.S. Supreme Court decision strengthening preemption defenses for FDA-regulated products recently appeared in amNY Law.

Kelly, leader of the firm’s Medical and Life Sciences Practice Group, discussed the 7-2 ruling in Monsanto Co. v. Durnell that came after decades of glyphosate litigation. Glyphosate is the active herbicide in Monsanto’s Roundup weedkiller.

Despite the World Health Organization’s International Agency for Research on Cancer classifying glyphosate as “probably carcinogenic” – a move that led to thousands of lawsuits producing billions in damages against Monsanto and Roundup – the U.S. Environmental Protection Agency (EPA) has conducted its own research and repeatedly ruled Roundup and similar herbicides do not need to carry a cancer warning. Despite the EPA determination, some courts have attempted to force the cancer-warning labels on to the herbicides.

The Supreme Court ruled such lawsuits are barred because the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) authorizes the EPA to regulate the use, sale and labeling of pesticides and it includes a requirement prohibiting states from imposing additional labeling requirements.

“While this is a major victory for Monsanto, it should also be viewed as a win for medical device and over-the-counter drug manufacturers that market products regulated by federal agencies, as the Supreme Court ruling holds that preemption clauses found in statutes governing federal agencies bar states from adding additional regulatory requirements,” Kelly wrote.

Harris Beach Murtha writes monthly opinion pieces for the publication. You can read Kelly’s full article here.

Authors

Kelly Jones Howell

Member
(212) 912-3652
khowell@harrisbeachmurtha.com
Attorney Advertising. Prior results do not guarantee a similar outcome. © 2026 Harris Beach Murtha Cullina PLLC
Content current as of November 14, 2026 4:26 pm